Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19293454 | 0.87 | — | — | |
| SCHEMBL20527653 | 0.79 | CA1 (0.33) | — | |
| SCHEMBL6722036 | 0.79 | MAPT (0.42) | MAPTALDH1A1GAANPC1LMNA | |
| SCHEMBL6862441 | 0.68 | MAPT (0.36) | MAPTALDH1A1GAANPC1LMNA | |
| SCHEMBL7912656 | 0.68 | MAPT (0.36) | MAPTALDH1A1GAANPC1LMNA | |
| SCHEMBL11843782 | 0.68 | PRSS1 (0.30) | — | |
| SCHEMBL17503455 | 0.67 | ALDH1A1 (0.32) | ALDH1A1LMNATSHR | |
| SCHEMBL8815894 | 0.67 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL20715180 | 0.67 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL8444553 | 0.67 | ALDH1A1 (0.32) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9956198-B2 | Furo[3,4-b]pyran compounds and pharmaceutical uses | VICTORIA LINK LIMITED (NZ) | 2018-05-01 | — | — | US | disclosed |
| US-9956198-B2 | Furo[3,4-b]pyran compounds and pharmaceutical uses | VICTORIA LINK LIMITED (NZ) | 2018-05-01 | — | — | US | disclosed |
| US-20170087124-A1 | FURO[3,4-b]PYRAN COMPOUNDS AND PHARMACEUTICAL USES | VICTORIA LINK LIMITED (NZ) | 2017-03-30 | — | — | US | disclosed |
| US-20170087124-A1 | FURO[3,4-b]PYRAN COMPOUNDS AND PHARMACEUTICAL USES | VICTORIA LINK LIMITED (NZ) | 2017-03-30 | — | — | US | disclosed |
| US-9556194-B2 | Furo[3,4-b]pyran compounds and pharmaceutical uses | VICTORIA LINK LIMITED (NZ) | 2017-01-31 | — | — | US | disclosed |
| US-9556194-B2 | Furo[3,4-b]pyran compounds and pharmaceutical uses | VICTORIA LINK LIMITED (NZ) | 2017-01-31 | — | — | US | disclosed |
| US-20160304532-A1 | FURO[3,4-b]PYRAN COMPOUNDS AND PHARMACEUTICAL USES | VICTORIA LINK LIMITED (NZ) | 2016-10-20 | — | — | US | disclosed |
| US-20160304532-A1 | FURO[3,4-b]PYRAN COMPOUNDS AND PHARMACEUTICAL USES | VICTORIA LINK LIMITED (NZ) | 2016-10-20 | — | — | US | disclosed |
| WO-2015084181-A1 | FURO[3,4-b]PYRAN COMPOUNDS AND PHARMACEUTICAL USES | VICTORIA LINK LIMITED (NZ) | 2015-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304532-A1 | FURO[3,4-b]PYRAN COMPOUNDS AND PHARMACEUTICAL USES | THPO, CD4, NFATC1 | MAPT 2681/4885ALDH1A1 3712/4885GAA 2807/4885 |
| US-20170087124-A1 | FURO[3,4-b]PYRAN COMPOUNDS AND PHARMACEUTICAL USES | THPO, CD4, NFATC1 | MAPT 2681/4885ALDH1A1 3712/4885GAA 2807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.